Clinical Trial

Left Septal or Deep Septal Pacing to Prevent Pacing-induced Cardiomyopathy

Study acronym: DEEP
Recruiting
View on ClinicalTrials.gov →
Summary
Multicenter randomized controlled trial which will include patients with left ventricular ejection fraction \>50% requiring a first implant of a cardiac pacemaker with expected high pacing percentages. Patients will be randomized 1:1 to right ventricular apical pacing vs left septal or deep septal pacing. The primary endpoint will be pacing-induced cardiomyopathy during the first year of follow-up.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-25.
Status change: Not Yet Recruiting → Recruiting 2024-07-12
Trial Details
NCT Number NCT06474819
Lead Sponsor Institut d'Investigació Biomèdica de Bellvitge
Collaborators: Fundació La Marató de TV3, Hospital Universitari de Bellvitge
Conditions Complete Heart Block, Second Degree Atrioventricular Block Möbitz Type II
Enrollment 326 participants
Start Date 2024-07-12
Primary Completion 2027-01-12 (estimated)
Study Completion 2027-01-12 (estimated)
Updated on ClinicalTrials.gov 2024-07-15